饮酒公共卫生政策与全球癌症、肝病及心血管疾病结局之间的关联
该生态学多国研究纳入169个国家,基于WHO 2010年酒精与健康全球信息系统及2010-2019年全球疾病负担数据,构建酒精准备指数(API,0最低、100最高)。API与酒精使用障碍患病率、酒精相关性肝病死亡率、肿瘤死亡率、酒精归因肝细胞癌及心血管疾病均呈负相关,且关联随时间增强。
要点
- API与酒精使用障碍患病率呈负相关(IRR 0.13;95%CI 0.03-0.60;p=0.010)。
- API与酒精相关性肝病死亡率呈负相关(IRR 0.14;95%CI 0.03-0.79;p=0.025)。
- API与酒精归因肝细胞癌(IRR 0.13;95%CI 0.02-0.65;p=0.014)及心血管疾病(IRR 0.09;95%CI 0.02-0.41;p=0.002)呈负相关。
核心结论
- API是量化酒精相关公共卫生政策建立稳健性的有用工具。
- API较高的国家观察到较低的酒精使用障碍患病率及较低的酒精相关性肝病、肿瘤、酒精归因肝细胞癌和心血管疾病死亡率。
- 研究结果鼓励全球制定和加强酒精相关政策。
研究设计与样本
- 生态学多国研究,纳入169个国家。
- 酒精相关政策数据来自WHO 2010年酒精与健康全球信息系统。
- 2010-2019年酒精相关健康后果数据来自全球疾病负担数据库。
- 采用多重对应分析估计酒精准备指数(API,0最低、100最高)。
- 采用调整的多层广义线性模型(泊松分布)按API估计结局的发病率比(IRR)。
主要发现
- 169个国家的API中位数为54(IQR 34.9-76.8)。
- API与酒精使用障碍患病率呈负相关(IRR 0.13;95%CI 0.03-0.60;p=0.010)。
- API与酒精相关性肝病死亡率呈负相关(IRR 0.14;95%CI 0.03-0.79;p=0.025)。
- API与肿瘤死亡率(IRR 0.09;95%CI 0.02-0.40;p=0.002)、酒精归因肝细胞癌(IRR 0.13;95%CI 0.02-0.65;p=0.014)及心血管疾病(IRR 0.09;95%CI 0.02-0.41;p=0.002)呈负相关。
- 关联在美洲、非洲和欧洲最强;关联随时间增强,酒精使用障碍患病率在2年后显著降低,酒精相关性肝病死亡率和酒精归因肝细胞癌发病率分别在基线API评估后4年和8年下降(p<0.05)。
关键数值与推荐
- 酒精相关公共卫生政策分为5个项目,包括低、中、强政策建立标准。
- API采用多重对应分析估计,0为最低建立程度、100为最高建立程度。
临床怎么用
- 原文未据此给出针对消化内科临床实践的具体推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The long-term impact of alcohol-related public health policies (PHPs) on disease burden is unclear. We aimed to assess the association between alcohol-related PHPs and alcohol-related health consequences. METHODS: We conducted an ecological multi-national study including 169 countries. We collected data on alcohol-related PHPs from the WHO Global Information System of Alcohol and Health 2010. Data on alcohol-related health consequences between 2010-2019 were obtained from the Global Burden of Disease database. We classified PHPs into five items, including criteria for low, moderate, and strong PHP establishment. We estimated an alcohol preparedness index (API) using multiple correspondence analysis (0 lowest and 100 highest establishment). We estimated an incidence rate ratio (IRR) for outcomes according to API using adjusted multilevel generalized linear models with a Poisson family distribution. RESULTS: The median API in the 169 countries was 54 [IQR 34.9-76.8]. The API was inversely associated with alcohol use disorder (AUD) prevalence (IRR 0.13; 95% CI 0.03-0.60; p = 0.010), alcohol-associated liver disease (ALD) mortality (IRR 0.14; 95% CI 0.03-0.79; p = 0.025), mortality due to neoplasms (IRR 0.09; 95% CI 0.02-0.40; p = 0.002), alcohol-attributable hepatocellular carcinoma (HCC) (IRR 0.13; 95% CI 0.02-0.65; p = 0.014), and cardiovascular diseases (IRR 0.09; 95% CI 0.02-0.41; p = 0.002). The highest associations were observed in the Americas, Africa, and Europe. These associations became stronger over time, and AUD prevalence was significantly lower after 2 years, while ALD mortality and alcohol-attributable HCC incidence decreased after 4 and 8 years from baseline API assessment, respectively (p <0.05). CONCLUSIONS: The API is a valuable instrument to quantify the robustness of alcohol-related PHP establishment. Lower AUD prevalence and lower mortality related to ALD, neoplasms, alcohol-attributable HCC, and cardiovascular diseases were observed in countries with a higher API. Our results encourage the development and strengthening of alcohol-related policies worldwide. IMPACT AND IMPLICATIONS: We first developed an alcohol preparedness index, an instrument to assess the existence of alcohol-related public policies for each country. We then evaluated the long-term association of the country's alcohol preparedness index in 2010 with the burden of chronic liver disease, hepatocellular carcinoma, other neoplasms, and cardiovascular disease. The strengthening of alcohol-related public health policies could impact long-term mortality rates from cardiovascular disease, neoplasms, and liver disease. These conditions are the main contributors to the global burden of disease related to alcohol use. Over time, this association has not only persisted but also grown stronger. Our results expand the preliminary evidence regarding the importance of public health policies in controlling alcohol-related health consequences.
引用
- Díaz LA, Fuentes-López E, Idalsoaga F, et al. Association between public health policies on alcohol and worldwide cancer, liver disease and cardiovascular disease outcomes. J Hepatol. 2023. PMID: 37992972. doi:10.1016/j.jhep.2023.11.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。